Immtech International, Inc. (IMM) Announces Registered Offering Of One Million Shares In Common Stock
2/8/2007 12:11:31 PM
More...
|
US FDA Grants Immtech International, Inc. (IMM)'s Oral Drug Candidate Pafuramidine (DB289) Orphan Drug Status For Treatment Of PCP
11/21/2006 8:47:09 AM
More...
|
Immtech International, Inc. (IMM) Becomes Immtech Pharmaceuticals, Inc.
3/23/2006 12:01:43 PM
More...
|
Immtech International, Inc. (IMM) Announces DB289's Name 'Pafuramidine Maleate'
3/13/2006 11:13:06 AM
More...
|
Immtech International, Inc. (IMM) Completes U.S. FDA Special Protocol Assessment
3/6/2006 1:02:48 PM
More...
|
Immtech International, Inc. (IMM) Completes Public Offering
2/14/2006 10:28:36 AM
More...
|
Immtech International, Inc. (IMM) Licenses Class Of Next Generation Anti-Malarial Drug Candidates From Tulane University School of Medicine
2/10/2006 2:40:13 PM
More...
|
Immtech International, Inc. (IMM) Reports Fiscal Third Quarter 2006 Results
2/10/2006 10:50:03 AM
More...
|
Immtech International, Inc. (IMM) Announces Pricing Of Common Stock Offering
2/8/2006 10:57:26 AM
More...
|
Immtech International, Inc. (IMM) Announces Investors Conference Call To Be Held On Thursday, February 9, 2006
2/3/2006 11:19:20 AM
More...
|
|